Skip to main content
Integrative Medicine Research logoLink to Integrative Medicine Research
. 2024 Sep 8;13(4):101086. doi: 10.1016/j.imr.2024.101086

Acupuncture treatment is associated with a decreased risk of dementia in patients with rheumatoid arthritis in Taiwan: A propensity-score matched cohort study

Hou-Hsun Liao a,b,1, Ming-Cheng Huang c,d,1, Yu-Chen Lee c,d, Cheng-Li Lin e, Mei-Yao Wu c,f, Peter Karl Mayer c,g,, Hung-Rong Yen a,c,g,h,i,
PMCID: PMC11465145  PMID: 39399823

Abstract

Background

The purpose of this study was to understand whether acupuncture can decrease the risk of dementia in patients with rheumatoid arthritis (RA).

Methods

Using the registry from the National Health Insurance Research Database of Taiwan, we carried out a 1:1 propensity-score matched cohort study to analyze patients with RA diagnosed between 2000 and 2010. The patients who received acupuncture therapy were grouped as acupuncture users (n = 9,919), while the others were grouped as non-acupuncture users (n = 19,331). After propensity-score matching, the final sample included 9,218 matched participants in both groups, and these participants were followed up until the end of 2011. We used a Cox regression model to adjust for age, sex, comorbidiy, and conventional drugs and compared the hazard ratios (HRs) of developing dementia in the acupuncture and non-acupuncture groups.

Results

Acupuncture users tended to be more female-dominant and younger than non-acupuncture users. After propensity-score matching, both groups have comparable demographic characteristics. Acupuncture users had a lower risk of dementia than non-acupuncture users (adjusted HR: 0.55, 95% CI: 0.46–0.66). The cumulative incidence of dementia in the acupuncture group was significantly lower than that in the non-acupuncture group (log-rank test, p < 0.001). Patients who received the combinational treatment of conventional drugs and acupuncture had a significantly lower risk of developing dementia (adjusted HR: 0.64, 95% CI: 0.56–0.73) compared to those who only received conventional drugs.

Conclusion

Acupuncture therapy is associated with a reduced risk of dementia in patients with RA. Further clinical and mechanistic studies are needed.

Keywords: Acupuncture, Dementia, Real-word data, Rheumatoid arthritis, Traditional Chinese medicine

1. Introduction

Rheumatoid arthritis (RA) is a chronic, multi-systemic, autoimmune inflammatory disease of unknown cause. Although there are a variety of systemic symptoms, the characteristic feature of established RA affects the joints in a symmetrical way, which can be persistent inflammatory synovitis and functional loss.1 It is a progressive disease that may cause cartilage damage and bone erosions and subsequent changes in joint integrity by synovial inflammation. Despite its destructive potential, the course of RA can be quite variable. Some patients may experience only a mild oligoarticular illness of brief duration with minimal joint damage, but most will have relentless progressive polyarthritis with marked functional impairment.

In addition to joint damage, there are some other systemic conditions in patients with RA, such as musculoskeletal system other than joints (e.g., bone and muscle) and organs (e.g., skin, eye, lung, heart, kidney, blood vessels, salivary glands, central and peripheral nervous systems, and bone marrow). These conditions occur in 40% of patients with RA.2,3 There are more and more evidences showing that both local and systemic inflammation may lead to neuroinflammation.4 The disease activity of RA is associated with impaired cognitive function.5 Dementia, which is one of the diseases of the nervous system, was found to have a higher incidence in patients with RA than that in patients without RA.4, 5, 6, 7, 8

Both conventional Western medicine and traditional Chinese medicine (TCM) have been covered by the National Health Insurance program in Taiwan, which was launched in 1995.9 Our previous study found that 27.3% of RA patients10 and 29.1% of Alzheimer's disease patients11 also visited TCM clinics. In Taiwan, approximately 10.9% of adults utilized acupuncture in 2011.9 It has been shown that treating RA patients with acupuncture improved symptoms in some studies.12,13 In addition, some studies have reported that there were benefits in treating disorders of the nervous system by acupuncture.14, 15, 16 For example, one clinical trial showed that treatment with acupuncture might have some beneficial effects on improvements in cognitive status and activities in patients with dementia.17 However, long-term follow-up information on whether acupuncture could affect the incidence of dementia in patients with RA is lacking.

In Taiwan, the extensive National Health Insurance (NHI) program has covered almost everyone in the total population (23 million people) since 1995.18 All claims’ data were collected in the National Health Insurance Research Database (NHIRD). To investigate the association between dementia and acupuncture in patients with RA, we analyzed the registry for catastrophic illness patients of the NHIRD of Taiwan. The potential sampling bias was reduced because this dataset included all clinically and radiographically confirmed RA patients with long-term follow-up.19 We hypothesized that acupuncture can reduced the incidence of dementia in RA patients. The aim of this study is to explore the protective effect of acupuncture on dementia in patients with RA.

2. Methods

2.1. Data source

We carried out a nationwide, population-based, 1:1 propensity score-matched cohort study by analyzing the registry for the catastrophic illnesses patient database (RCIPD) from the NHIRD, which contained almost all the RA cases. Diagnostic methods were based on the code of The International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM).

In Taiwan, the NHI program covered almost all the necessary Western medical services and TCM services (Chinese herbal remedies, acupuncture/moxibustion, and tuina/manipulative therapies). Patients can choose TCM or Western medicine services freely. Only licensed TCM or Western medicine physicians are qualified for reimbursement. The large-scale real-world data, NHIRD, comprise de-identified information regarding medical care facilities, specialties, sex, birth dates, visit dates, prescriptions, management, cost and diagnosis codes in the ICD-9-CM format.18,19 The RCIPD is a part of the NHIRD. It was set up for the diseases that required more intensive care and includes approximately 30 disease categories, such as cancer, schizophrenia, end-stage renal disease, lupus, rheumatoid arthritis and cerebral palsy.20 The patients with RA were distributed for catastrophic illness certificates as long as they received complete clinical and blood evaluation, followed by cautious and routine review by rheumatologists assigned by the National Health Insurance Administration. Thus, the accuracy of the diagnosis of the patients with RA cases in this study has high credibility.

2.2. Study cohort identification

The flow chart for the selection of RA cases is illustrated in Fig. 1. With all 23,000,000 beneficiaries in the NHI program, the patients (n = 47,531) with a diagnosis of RA (International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code: 714.0) in the RCIPD of NHIRD were included in this study. There were 30,454 newly diagnosed RA patients in 2000–2010. After the cases who had missing information for age or sex and less than 18 years old (n = 814) and diagnosis date of dementia (ICD-9-CM: 290, 294.1, 331.0–331.2) before the diagnosis date of RA (n = 390) were excluded, the patients who received acupuncture therapy were grouped as acupuncture users (n = 9919), while the others were grouped as non-acupuncture users (n = 19,331). We used a 1:1 propensity score match by sex, age (per 5 years), all comorbidities, Charlson comorbidity index (CCI) score,21 conventional drug use (oral steroid, NSAID, statin), diagnosis year of RA and index year. Thus, the final grouping was 9218 matched cases in both groups and then followed up until the end of 2011.

Fig. 1.

Fig 1

Recruitment flowchart. Patients with rheumatoid arthritis diagnosed from 2000 to 2010 were recruited. These patients were categorized as acupuncture users or non-acupuncture users according to the inclusion of acupuncture therapies in their treatment. Abbreviations: rheumatoid arthritis (RA); International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM); National Health Insurance Research Database (NHIRD).

2.3. Covariate assessment

The demographic characteristics and claims data of this study cohort were collected and analyzed. The comorbidity of these patients was determined by ICD-9-CM codes: diabetes mellitus (250), hypertension (401–415), hyperlipidemia (272), congestive heart failure (402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 428.0), depression (296.2–296.3, 300.4, 311), anxiety (300.0, 300.2, 300.3, 308.3, 308.91), alcoholism (291, 303, 305.00, 305.01, 305.02, 305.03, 790.3 and V11.3), tobacco use (305.1), obesity (278 and A183) and sleep disorders (307.4 and 780.5). Outcome measurement is the event of dementia (ICD-9-CM: 290, 294.1, 331.0–331.2), including vascular dementia (ICD-9-CM: 290.4) and Alzheimer's disease (ICD-9-CM: 331.0), during the follow-up period until the end of 2011. The date of the first acupuncture intervention was defined as the index date. Patients in the non-acupuncture group were randomly assigned a matched index date to minimize the immortal bias. Patients diagnosed as having dementia within one year after their initial diagnosis of RA were excluded from the cumulative incidence of dementia in the Kaplan-Meier curve.

Types of acupuncture and disease categories in the acupuncture cohort

We also identified patients who received acupuncture (treatment code: B41, B42, B43, B44, B45, B46, B80, B81, B82, B83, B84, B85, B86, B87, B88, B89, B90, B91, B92, B93, B94, P27041, P31103, P31206, P32103, P33031, P33032) and electroacupuncture (treatment code: B43, B44, B85, B86, B87, B88, B89, P33032) as previously described.22 One course of acupuncture treatment usually includes 6 sessions in a month. Disease categories/diagnoses for patients with RA in the acupuncture cohort were identified by the ICD-9-CM codes.

2.4. Statistical analyses

We used standardized mean differences to compare the baseline characteristics of the acupuncture and non-acupuncture groups. Standardized mean differences less than 0.2 indicated that there is no significant difference in the average or distribution between the two groups.23 Cox proportional hazards regression was used to calculate the HR and 95% CI for each variable. The discrepancy between the two groups in the follow-up development of developing dementia was measured using the Kaplan-Meier method and the log-rank test. SAS 9.4 (SAS Institute, Cary, NC, USA) and R software (R Foundation for Statistical Computing, Vienna, Austria) to perform the statistical analyses and create the figures. p < 0.05 in two-tailed tests was considered statistically significant.

2.5. Ethics statement

The NHIRD was provided by the National Health Insurance Administration and managed by Ministry of Health and Welfare, Taiwan. For guarding enrollees’ privacy, every offered dataset was deidentified and encrypted. Therefore, it was impossible to recognize individual patients by any means. This study was approved by the Research Ethics Committee of China Medical University and Hospital, Taiwan (CMUH104-REC2–115).

3. Results

We identified 30,454 newly diagnosed RA patients in 2000–2010. After excluding missing information for age or sex and less than 18 years old (n = 814) and those diagnosed with dementia before the diagnosis date of RA (n = 390), a total of 29,250 RA patients were included. Acupuncture users tended to be more female-dominant and younger than non-acupuncture users. Comorbidities varied between the two groups, with more acupuncture users having hyperlipidemia, depression, anxiety, obesity and sleep disorders (Supplementary Table 1).

After further performing 1:1 propensity-score matching by sex, age, all comorbidities, conventional drug use (oral steroids, NSAIDs, statin), the initial diagnostic year of RA, and index year, there were 9,218 patients in both the acupuncture and non-acupuncture treatment groups (Fig. 1).

There were no differences in sex, age, Charlson comorbidity index (CCI) score, conventional drug use, and comorbidity of patients in the two cohorts (Table 1).

Table 1.

Characteristics of rheumatoid arthritis patients according to whether they received acupuncture.

Variables Rheumatoid Arthritis
Standardized mean difference
Received acupuncture
No (n = 9218)
Yes (n = 9218)
n % n %
Sex
 Female 7460 80.9 7488 81.2 0.008
 Male 1758 19.1 1730 18.8 0.008
Age group
 18–39 1769 19.2 1489 16.2 0.08
 40–59 5448 59.1 6080 66.0 0.142
 ≥60 2001 21.7 1649 17.9 0.096
 Mean±SD (years) 52.7 ± 14.4 52.7 ± 12.9 0.000
Baseline Comorbidity
 Diabetes mellitus 457 4.96 458 4.97 0.000
 Hypertension 3114 33.8 3114 33.8 0.000
 Hyperlipidemia 2420 26.3 2461 26.7 0.01
 Congestive heart failure 349 3.79 341 3.70 0.005
 Depression 855 9.28 859 9.32 0.001
 Anxiety 2026 22.0 2030 22.0 0.001
 Alcoholism 142 1.54 154 1.67 0.01
 Tobacco used 37 0.40 42 0.46 0.008
 Obesity 96 1.04 99 1.07 0.003
 Sleep disorder 3361 36.5 3385 36.7 0.005
Charlson Comorbidity Index (CCI)
 0 5663 61.4 5662 61.4 0.000
 1 1945 21.1 1929 20.9 0.004
 2 917 9.95 991 10.8 0.026
 3+ 693 7.52 636 6.90 0.024
Length of days of hospitalization during the study period 13.9 14.9 13.8 14.7 0.001
Conventional drug used
 Oral steroid 8730 94.7 8721 94.6 0.004
 NSAID 9166 99.4 9182 99.6 0.025
 Statin 1757 19.1 1749 19.0 0.002
Types of acupuncture
 Manual acupuncture 7954 86.3
 Electroacupuncture 350 3.80
 Combined manual acupuncture and electroacupuncture 914 9.92
Duration between rheumatoid arthritis diagnosis date and the index date, days (mean, median) (948,700) (941,653) 0.008
The number of acupuncture courses, (mean, median) (7.73,3.00)

The means (medians) of the follow-up period were 4.15 (3.63) and 3.56 (2.95) years for the acupuncture cohort and the non-acupuncture cohort, respectively. Each acupuncture course usually includes 6 acupuncture sessions in one month.

In the RA patients, we found that acupuncture users had a lower incidence of dementia compared with patients without acupuncture (adjusted HR: 0.55, 95% CI: 0.46–0.66) (Table 2). The prevalence of dementia increases with age. Compared to the incidence in the 18- to 39-year-old group, the risk was much higher in the 40- to 59-year-old (adjusted HR: 6.62, 95% CI: 2.92–15.0) and > 60-year-old (adjusted HR: 43.9, 95% CI: 19.3–99.9) groups. Furthermore, patients with diabetes (adjusted HR: 1.44, 95% CI: 1.10–1.89), hypertension (adjusted HR: 1.52, 95% CI: 1.24–1.86), hyperlipidemia (adjusted HR: 1.23, 95% CI: 1.01–1.48), congestive heart failure (adjusted HR: 1.39, 95% CI: 1.06–1.83), depression (adjusted HR: 1.66, 95% CI: 1.06–1.83) also had a higher risk of developing dementia than those without these comorbidities. For patients with CCI score 0, patients with subgroups of CCI score 1, CCI score 2, and CCI score ≥ 3, the adjusted HRs of dementia were 1.39, 1.60, and 2.01, respectively.

Table 2.

Cox model with hazard ratios and 95% confidence intervals of dementia associated with received acupuncture and covariates among rheumatoid arthritis patients.

Variables No. of event (n = 546) Crude*
Adjusted
HR (95% CI) p-value HR (95% CI) p-value
Received acupuncture
 No 331 1.00 reference 1.00 reference
 Yes 215 0.56 (0.47, 0.67) <0.001 0.55 (0.46, 0.66) <0.001
Sex
 Female 437 1.00 reference 1.00 reference
 Male 109 1.09 (0.88,1.34) 0.43 0.97 (0.78, 1.20) 0.78
Age group
 18–39 6 1.00 reference 1.00 reference
 40–59 164 7.78 (3.45, 17.6) <0.001 6.62 (2.92, 15.0) <0.001
 ≥60 376 67.8 (30.3, 151.8) <0.001 43.9 (19.3, 99.9) <0.001
Baseline Comorbidity (ref=no comorbidity)
 Diabetes mellitus 67 3.23 (2.50,4.18) <0.001 1.44 (1.10, 1.89) 0.008
 Hypertension 360 4.28 (3.58,5.11) <0.001 1.52 (1.24, 1.86) <0.001
 Hyperlipidemia 226 2.29 (1.93, 2.72) <0.001 1.23 (1.01, 1.48) 0.04
 Congestive heart failure 62 4.16 (3.20, 5.43) <0.001 1.39 (1.06, 1.83) 0.02
 Depression 87 2.27 (1.80, 2.86) <0.001 1.66 (1.30, 2.14) <0.001
 Anxiety 161 1.81 (1.51, 2.18) <0.001 1.16 (0.95, 1.42) 0.15
 Alcoholism 8 1.15 (0.57, 2.32) 0.69 1.88 (0.88, 4.02) 0.10
 Tobacco used 1 0.65 (0.09, 4.60) 0.66 0.33 (0.04, 2.69) 0.30
 Obesity 4 0.87 (0.32, 2.31) 0.77 0.81 (0.30, 2.17) 0.67
 Sleep disorder 249 1.87 (1.58, 2.21) <0.001 1.11 (0.92, 1.34) 0.29
Charlson Comorbidity Index (CCI)
 0 221 1.00 reference 1.00 reference
 1 138 1.91 (1.54, 2.36) <0.001 1.39 (1.12, 1.72) 0.003
 2 97 2.80 (2.21, 3.56) <0.001 1.60 (1.25, 2.05) <0.001
 3+ 90 4.59 (3.59, 5.86) <0.001 2.01 (1.53, 2.63) <0.001
Conventional drug used
 Oral steroid 513 0.73 (0.51, 1.04) 0.08 0.55 (0.38, 0.78) 0.001
 NSAID 538 0.16 (0.08, 0.32) <0.001 0.29 (0.14–0.60) <0.001
 Statin 128 1.25 (1.03, 1.52) 0.03 0.72 (0.58, 0.89) 0.003

Crude HR represented relative hazard ratio.

Adjusted HR represented adjusted hazard ratio: mutually adjusted for received acupuncture, length of days of hospitalization during the study period, age, sex, diabetes mellitus, hypertension, hyperlipidemia, congestive heart failure, depression, anxiety, alcoholism, tobacco used, obesity, sleep disorder, Charlson Comorbidity Index, oral steroid, NSAID and statin in Cox proportional hazard regression.

The patients who took oral steroids (adjusted HR: 0.55, 95% CI: 0.38–0.78), NSAID (adjusted HR: 0.29, 95% CI: 0.14–0.60) or statins (adjusted HR: 0.72, 95% CI: 0.58–0.89) had a significantly lower chance of getting dementia.

Compared with the non-acupuncture cohort, acupuncture users had a lower incidence rate of dementia, especially patients older than 60 years (adjusted HR: 0.50, 95% CI: 0.46–0.65) (Table 3). The incidence of dementia was significantly lower in the acupuncture group when the patients had comorbidities such as diabetes mellitus (adjusted HR: 0.51, 95% CI: 0.31–0.86), hypertension (adjusted HR: 0.48, 95% CI: 0.39–0.60), hyperlipidemia (adjusted HR: 0.52, 95% CI: 0.40–0.68), congestive heart failure (adjusted HR: 0.40, 95% CI: 0.23–0.69), depression (adjusted HR: 0.56, 95% CI: 0.37–0.86), anxiety (adjusted HR: 0.59, 95% CI: 0.43–0.82), or sleep disorder (adjusted HR: 0.52, 95% CI: 0.40–0.67). Among RA patients taking oral steroids (adjusted HR: 0.55, 95% CI: 0.46–0.65), NSAIDs (adjusted HR: 0.55, 95% CI: 0.46–0.66), or statins (adjusted HR: 0.53, 95% CI: 0.37–0.76), the chances of getting dementia in the acupuncture group were also significantly decreased.

Table 3.

Incidence rates, hazard ratios and confidence intervals of dementia in rheumatoid arthritis patients who received and did not receive acupuncture in the stratification of sex, age, comorbidities and conventional drug used.

Variables Rheumatoid Arthritis Patients Received Acupuncture
Compared with non-acupuncture users
No (n = 9218)
Yes (n = 9218)
Crude HR (95% CI) Adjusted HR (95% CI)
Event Person years IR Event Person years IR
Total 331 32,771 10.1 215 38,228 5.62 0.56(0.47, 0.67)*** 0.55(0.46, 0.65)***
Sex
 Female 266 26,788 9.93 171 30,994 5.52 0.56(0.46, 0.68)*** 0.57(0.47, 0.69)***
 Male 65 5984 10.9 44 7235 6.08 0.56(0.39, 0.83)** 0.47(0.32, 0.70)***
Age group
 18–39 5 6811 0.73 1 6262 0.16 0.21(0.03, 1.83) 0.17(0.02, 1.65)
 40–59 87 20,246 4.30 77 25,649 3.00 0.70(0.51, 0.95)* 0.67(0.49, 0.91)**
 ≥60 239 5714 41.8 137 6317 21.7 0.52(0.42, 0.65)*** 0.50(0.40, 0.62)***
Baseline Comorbidity
 Diabetes mellitus
 No 289 31,515 9.17 190 36,568 5.20 0.57(0.47, 0.68)*** 0.55(0.46, 0.67)***
 Yes 42 1256 33.4 25 1660 15.1 0.44(0.27, 0.73)** 0.51(0.31, 0.86)*
 Hypertension
 No 103 22,963 4.49 83 25,969 3.20 0.71(0.54, 0.95)* 0.70(0.52, 0.94)*
 Yes 228 9809 23.2 132 12,259 10.8 0.47(0.38, 0.58)*** 0.48(0.39, 0.60)***
 Hyperlipidemia
 No 194 25,281 7.67 126 29,045 4.34 0.57(0.45, 0.71)*** 0.57(0.45, 0.71)***
 Yes 137 7491 18.3 132 12,259 10.8 0.53(0.41, 0.69)*** 0.52(0.40, 0.68)***
 Congestive heart failure
 No 289 31,857 9.07 195 37,048 5.26 0.58(0.49, 0.70)*** 0.56(0.47, 0.68)***
 Yes 42 915 45.9 20 1180 16.9 0.37(0.22, 0.64)*** 0.40(0.23, 0.69)***
 Depression
 No 278 30,367 9.15 181 35,207 5.14 0.56(0.47, 0.68)*** 0.55(0.45, 0.66)***
 Yes 53 2404 22.1 34 3021 11.3 0.53(0.35, 0.82)** 0.56(0.37, 0.86)**
 Anxiety
 No 238 26,714 8.91 147 31,058 4.73 0.53(0.44, 0.66)*** 0.52(0.43, 0.65)***
 Yes 93 6057 15.4 68 7170 9.48 0.62(0.46, 0.85)** 0.59(0.43, 0.82)**
 Alcoholism
 No 326 32,379 10.1 212 37,737 5.62 0.56(0.47, 0.67)*** 0.55(0.46, 0.65)***
 Yes 5 392 12.8 3 491 6.11 0.49(0.12, 2.07) 0.42(0.06, 3.18)
 Tobacco used
 No 331 32,684 10.1 214 38,123 5.61 0.56(0.47, 0.66)*** 0.54(0.46, 0.65)***
 Yes 0 87.4 0.00 1 104 9.57
 Obesity
 No 330 32,500 10.2 212 37,911 5.59 0.56(0.47, 0.66)*** 0.54(0.45, 0.64)***
 Yes 1 271 3.69 3 317 9.45 2.75(0.29, 26.4)
 Sleep disorder
 No 175 22,949 7.63 122 26,089 4.68 0.61(0.49, 0.77)*** 0.57(0.45, 0.72)***
 Yes 156 9823 15.9 93 12,139 7.66 0.49(0.38, 0.64)*** 0.52(0.40, 0.67)***
Charlson Comorbidity Index (CCI)
 0 128 21,203 6.04 93 23,985 3.88 0.64(0.49, 0.84)** 0.62(0.47, 0.81)***
 1 83 7013 11.8 55 7794 7.06 0.60(0.43, 0.85)** 0.58(0.41, 0.82)**
 2 64 2809 22.8 33 4242 7.78 0.35(0.23, 0.54)*** 0.36(0.23, 0.55)***
 3+ 56 1747 32.1 34 2206 15.4 0.49(0.32, 0.76)** 0.51(0.33, 0.79)**
Drug used
 Oral steroid
 No 19 1406 13.5 14 1725 8.12 0.65(0.32, 1.29) 0.65(0.31, 1.38)
 Yes 312 31,365 9.95 201 36,503 5.51 0.56(0.47, 0.66)*** 0.55(0.46, 0.65)***
 NSAID
 No 6 62 96.1 2 94 21.3 0.35(0.07, 1.76)
 Yes 325 32,709 9.94 213 38,134 5.59 0.57(0.48, 0.67)*** 0.55(0.46, 0.66)***
 Statin
 No 252 26,162 9.63 166 30,799 5.39 0.57(0.47, 0.69)*** 0.56(0.46, 0.68)***
 Yes 79 6609 12.0 49 7429 6.60 0.54(0.38, 0.77)*** 0.53(0.37, 0.76)***

Abbreviation: IR, incidence rates, per 1000 person-years; HR, hazard ratio; CI, confidence interval.

Adjusted HR: adjusted for accepted acupuncture, length of days of hospitalization during the study period, age, sex, diabetes mellitus, hypertension, hyperlipidemia, congestive heart failure, depression, anxiety, alcoholism, tobacco used, obesity, sleep disorder, Charlson Comorbidity Index, oral steroid, NSAID and statin in Cox proportional hazards regression.

*p:<0.05; ** p < 0.01; *** p < 0.001.

To identify the incidence rates of different types of dementia in patients with RA in both cohorts, we further analyzed the incidence rates of vascular dementia and Alzheimer's disease in these patients (Table 4). We found that acupuncture users had a lower incidence rate of vascular dementia than patients not receiving acupuncture (adjusted HR: 0.47, 95% CI: 0.29–0.77).

Table 4.

Incidence rates, hazard ratio and confidence intervals of vascular dementia and Alzheimer's disease for rheumatoid arthritis patients who received and did not receive acupuncture in the stratification of sex, age, comorbidities and conventional drugs used.

Outcome Rheumatoid Arthritis Patients Received Acupuncture
Compared with non-acupuncture users
No (n = 9218)
Yes (n = 9218)
Crude HR Adjusted HR
Event Person years IR Event Person years IR (95% CI) (95% CI)
Vascular dementia 42 32,808 1.28 25 38,240 0.65 0.50 (0.30, 0.081)** 0.47 (0.29, 0.77)**
Alzheimer's disease 25 32,805 0.76 19 38,238 0.50 0.63 (0.35, 1.15) 0.63 (0.35, 1.15)

Abbreviation: IR, incidence rates, per 1000 person-years; HR, hazard ratio; CI, confidence interval.

Adjusted HR: adjusted for received acupuncture, length of days of hospitalization during the study period, age, sex, diabetes mellitus, hypertension, hyperlipidemia, congestive heart failure, depression, anxiety, alcoholism, tobacco used, obesity, sleep disorder, Charlson Comorbidity Index, oral steroid, NSAID and statin use in Cox proportional hazards regression.

* p:<0.05.

To compare the differences in the incidence rate of dementia in patients with different types of treatment, we further analyzed the prevalence of dementia in patients who received only conventional treatment, only acupuncture, and both conventional treatment and acupuncture (Table 5). We found that patients who received the combination treatment of conventional drugs and acupuncture had a significantly lower risk of developing dementia (adjusted HR: 0.64, 95% CI: 0.56–0.73).

Table 5.

Cox model with hazard ratios and 95% confidence intervals of dementia associated with receiving only conventional Western drugs, only acupuncture or both acupuncture and conventional Western drugs among rheumatoid arthritis patients.

Variables n No. of event (n = 543) Crude*
Adjusted
HR (95% CI) p-value HR (95% CI) p-value
Treatment
 Only conventional Western drugs used 9201 328 1.00 reference 1.00 reference
 Only acupuncture used 63 1 3.15 (0.44, 22.4) 0.2521 0.54 (0.06, 5.25) 0.6149
 Combined Western drugs and acupuncture 9205 214 0.56 (0.47–0.67) <0.0001 0.64 (0.56–0.73) <0.0001

Crude HR represented relative hazard ratio;.

Adjusted HR represented adjusted hazard ratio: mutually adjusted for accepted acupuncture, length of days of hospitalization during the study period, age, sex, diabetes mellitus, hypertension, hyperlipidemia, congestive heart failure, depression, anxiety, alcoholism, tobacco used, obesity, sleep disorder, Charlson Comorbidity Index, oral steroid, NSAID and statin in Cox proportional hazard regression.

Based on the Kaplan–Meier curves, we found that the cumulative incidence of dementia in the acupuncture cohort was significantly lower than that in the non-acupuncture cohort (log-rank test, p < 0.001) (Fig. 2).

Fig. 2.

Fig 2

Cumulative incidence of dementia between the acupuncture cohort and the non-acupuncture cohort. The cumulative incidence of dementia in the acupuncture cohort was significantly lower than that in the non-acupuncture cohort (log-rank test, p < 0.001).

Since that sometimes the patients also received Chinese herbal medicines in the acupuncture clinic, we also identified the commonly prescribed Chinese herbal medicines, including single herbs and herbal formulas. We have also calculated the impact of these herbs and measured the crude HR and adjusted HR of developing dementia (Supplementary Table 2).

4. Discussion

The real-world data from the NHIRD provide evidence consistent with our hypothesis that acupuncture might be beneficial for preventing the occurrence of dementia in patients with RA. Acupuncture users had a lower incidence of dementia than non-acupuncture users. We discovered that the cumulative incidence of dementia in the acupuncture cohort was significantly lower than that in the non-acupuncture cohort through a Kaplan–Meier analysis. Furthermore, the chances of getting dementia in the acupuncture group also decreased in RA patients taking oral steroids, NSAIDs, or statins. In addition, adjunctive acupuncture therapy and conventional drug use had a significantly lower risk of developing dementia than the use of conventional Western drugs alone.

Aging is the strongest risk factor for dementia. Some studies have shown that approximately 85 percent of dementia individuals are older than 75 years of age.24,25 It is in substantial agreement with our results that the incidence of dementia increases with age in patients with RA as well.

Among the baseline comorbidities we investigated, diabetes, hypertension, and depression had a higher risk of developing dementia. Furthermore, these three comorbidities were included in nine potentially modifiable risk factors of dementia reported by the Lancet Commission recently.26 We found that receiving acupuncture showed benefits in preventing dementia in RA patients with comorbidities such as diabetes mellitus, hypertension, hyperlipidemia, depression, or anxiety. Taken together, receiving acupuncture in RA patients with DM or hypertension might be important for preventing the occurrence of dementia.

The definitive mechanism of acupuncture treatment remains unclear.27 Nevertheless, since acupuncture was often used to treat disorders of the nervous system (e.g., traumatic brain injury,28 stroke,29 cerebral palsy,20 and epilepsy30) and psychological systems (e.g., depressive disorder,31 insomnia32 and anxiety33), it seems reasonable that acupuncture could reduce the incidence of dementia in patients with RA in this study. On the other hand, some studies showed anti-inflammatory effects of acupuncture.34,35 Acupuncture could not only relieve pain through endorphin,36 adenosine37 and orexin38 but also reduce inflammation through dopamine.39 Since there was a connection between chronic inflammation and dementia,8 the decrease in the incidence of dementia in patients with RA might be due to the anti-inflammatory effects of acupuncture. Additionally, taking oral steroids reduces the incidence of dementia in this study. This might be considered additional evidence of inflammation associated with dementia.

Among two different types of dementia of patients with RA, the incidence was reduced by acupuncture in vascular dementia, but not Alzheimer's disease. This result might suggest that the effect of acupuncture came from improving cardiovascular function. This is compatible with other studies of acupuncture.15, 16, 17,20

This study provided valuable information regarding the prevention of and clinical recommendation for dementia in patients with RA. Furthermore, it could provide directions for future clinical trials for treating patients with RA. The strength of this study included the following three points of view: (1) based on a review of the literature and our knowledge, this study is the first large-scale research to investigate the association between dementia and acupuncture of patients with RA. (2) All patients with catastrophic illness certificates of RA were included in this study. All patients were confirmed to be diagnosed by rheumatologists with clinical and blood sample evaluations. Because NHIRD covered more than 99% of the Taiwanese population, the potential selection bias was thus minimized (3) The medical insurance of the NHI system provided a low-cost and convenient medical service that covered almost all residents in Taiwan.40 In addition, more than 90% of medical institutions, including hospitals and clinics at all levels, are covered in the NHI program.40 All RA patients were waived of co-payment when they visited rheumatologist or TCM doctors for the treatment of RA in the NHI program. Thus, people are not faced with differences in price when choosing Chinese medicine or Western medicine.

However, this study has some limitations. First, in patients receiving acupuncture treatment, the method of acupuncture is not standardized, including position and duration of treatment. Instead, the data reflects a real-world practice in the clinics. Second, since there were no disease severity and imaging data in the NHIRD, we were unable to evaluate the impact of disease severity on outcomes from this study although we have matched the two cohorts by a propensity-score matching method. Third, the mechanism of action of acupuncture remains unclear. Thus, we look forward to future clinical trials and mechanistic studies to explore the mechanisms and clinical efficacy of the preventive effect of acupuncture on dementia in patients with RA based on this study.

In conclusion, our present study suggests that acupuncture treatment is associated with a reduced risk of dementia in patients with RA in Taiwan. This valuable information could provide some ideas for future clinical and mechanistic studies.

Author contributions

Conceptualization and methodology: HRY, PKM and CLL. Software: CLL. Validation: HHL, MCH, CLL, MYW and HRY. Formal analysis: CLL. Investigation: HHL, MCH, YCL, CLL, PKM, MYW, HRY. Resources: HHL and HRY. Writing—original draft: HHL, MCH, MYW, PKM and HRY. Writing—review and editing: PKM, MYW and HRY. Supervision and project administration: HRY.

Declaration of competing interest

The authors declare that they have no conflicts of interest.

Funding

This work was financially supported by the "Chinese Medicine Research Center, China Medical University” from the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (CMRC-CHM-2). This study was also supported in part by China Medical University Hospital (DMR-111-192, DMR-112-007, DMR-112-008), Ministry of Health and Welfare Clinical Trial Center (MOHW113-TDU-B-212-1140094). None of the funders and institutions listed had a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Ethical statement

This study was approved by the Research Ethics Committee of China Medical University and Hospital, Taichung, Taiwan (CMUH104-REC2–115). The patient consent was exempted for the total anonymity of all research data in this study.

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Footnotes

Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.imr.2024.101086.

Supplementary Table 1. Characteristics of rheumatoid arthritis patients according to whether they received acupuncture prior to propensity score matching.

Supplementary Table 2. Hazard Ratios and 95% confidence intervals of dementia risk associated with type of Chinese herbal medicines among RA patients.

Contributor Information

Peter Karl Mayer, Email: piotrmayer@mail.cmu.edu.tw.

Hung-Rong Yen, Email: hungrongyen@mail.cmu.edu.tw.

Appendix. Supplementary materials

mmc1.pdf (202.1KB, pdf)

References

  • 1.Smolen J.S., Aletaha D., McInnes I.B. Rheumatoid arthritis. Lancet. 2016;388:2023–2038. doi: 10.1016/S0140-6736(16)30173-8. [DOI] [PubMed] [Google Scholar]
  • 2.Myasoedova E., Crowson C.S., Turesson C., et al. Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study. J Rheumatol. 2011;38:983–989. doi: 10.3899/jrheum.101133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Turesson C., O'Fallon W.M., Crowson C.S., et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62:722–727. doi: 10.1136/ard.62.8.722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Mason A., Holmes C., Edwards C.J. Inflammation and dementia: using rheumatoid arthritis as a model to develop treatments? Autoimmun Rev. 2018;17:919–925. doi: 10.1016/j.autrev.2018.04.001. [DOI] [PubMed] [Google Scholar]
  • 5.Katchamart W., Narongroeknawin P., Phutthinart N., et al. Disease activity is associated with cognitive impairment in patients with rheumatoid arthritis. Clin Rheumatol. 2019;38:1851–1856. doi: 10.1007/s10067-019-04488-3. [DOI] [PubMed] [Google Scholar]
  • 6.Vitturi B.K., Nascimento B.A.C., Alves B.R., et al. Cognitive impairment in patients with rheumatoid arthritis. J Clin Neurosci: official J Neurosurg Soc Australasia. 2019;69:81–87. doi: 10.1016/j.jocn.2019.08.027. [DOI] [PubMed] [Google Scholar]
  • 7.Shin S.Y., Julian L., Katz P. The relationship between cognitive function and physical function in rheumatoid arthritis. J Rheumatol. 2013;40:236–243. doi: 10.3899/jrheum.120871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ungprasert P., Wijarnpreecha K., Thongprayoon C. Rheumatoid arthritis and the risk of dementia: a systematic review and meta-analysis. Neurol India. 2016;64:56–61. doi: 10.4103/0028-3886.173623. [DOI] [PubMed] [Google Scholar]
  • 9.Wu M.Y., Lee Y.C., Lin C.L., et al. Trends in use of acupuncture among adults in Taiwan from 2002 to 2011: a nationwide population-based study. PLoS One. 2018;13 doi: 10.1371/journal.pone.0195490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Huang M.C., Pai F.T., Lin C.C., et al. Characteristics of traditional Chinese medicine use in patients with rheumatoid arthritis in Taiwan: a nationwide population-based study. J Ethnopharmacol. 2015;176:9–16. doi: 10.1016/j.jep.2015.10.024. 2015/10/21. [DOI] [PubMed] [Google Scholar]
  • 11.Lai C.Y., Wu M.Y., Chiang J.H., et al. Utilization of Western medicine and traditional Chinese medicine among patients with Alzheimer's disease in Taiwan: a nationwide population-based study. Eur J Neurol. 2017;24:1166–1172. doi: 10.1111/ene.13361. 2017/07/27. [DOI] [PubMed] [Google Scholar]
  • 12.Bernateck M., Becker M., Schwake C., et al. Adjuvant auricular electroacupuncture and autogenic training in rheumatoid arthritis: a randomized controlled trial. Auricular acupuncture and autogenic training in rheumatoid arthritis. Forsch Komplementmed. 2008;15:187–193. doi: 10.1159/000141929. [DOI] [PubMed] [Google Scholar]
  • 13.Casimiro L., Barnsley L., Brosseau L., et al. Acupuncture and electroacupuncture for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev. 2005 doi: 10.1002/14651858.CD003788.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sui Y., Ma T., Bian D., et al. [Clinical observation of post-stroke upper limb spasmodic hemiplegia treated with relaxing needling technique combined with wheat-grain moxibustion] Zhongguo Zhen Jiu. 2015;35:423–427. [PubMed] [Google Scholar]
  • 15.Chen B., Tao J., Lin Y., et al. Electro-acupuncture exerts beneficial effects against cerebral ischemia and promotes the proliferation of neural progenitor cells in the cortical peri-infarct area through the Wnt/beta-catenin signaling pathway. Int J Mol Med. 2015;36:1215–1222. doi: 10.3892/ijmm.2015.2334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Chuang S.F., Shih C.C., Yeh C.C., et al. Decreased risk of acute myocardial infarction in stroke patients receiving acupuncture treatment: a nationwide matched retrospective cohort study. BMC Complement Altern Med. 2015;15:318. doi: 10.1186/s12906-015-0828-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Shi G.X., Li Q.Q., Yang B.F., et al. Acupuncture for Vascular Dementia: a Pragmatic Randomized Clinical Trial. Scientific World J. 2015;2015 doi: 10.1155/2015/161439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Lin L.Y., Warren-Gash C., Smeeth L., et al. Data resource profile: the National Health Insurance Research Database (NHIRD) Epidemiol Health. 2018;40 doi: 10.4178/epih.e2018062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hsing A.W., Ioannidis J.P. Nationwide population science: lessons from the Taiwan national health insurance research database. JAMA Intern Med. 2015;175:1527–1529. doi: 10.1001/jamainternmed.2015.3540. [DOI] [PubMed] [Google Scholar]
  • 20.Liao H.H., Yen H.R., Muo C.H., et al. Complementary traditional Chinese medicine use in Children with cerebral palsy: a nationwide retrospective cohort study in Taiwan. BMC Complement Altern Med. 2017;17:155. doi: 10.1186/s12906-017-1668-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–619. doi: 10.1016/0895-4356(92)90133-8. 1992/06/01. [DOI] [PubMed] [Google Scholar]
  • 22.Wu M.Y., Huang M.C., Liao H.H., et al. Acupuncture decreased the risk of coronary heart disease in patients with rheumatoid arthritis in Taiwan: a Nationwide propensity score-matched study. BMC Complement Altern Med. 2018;18:341. doi: 10.1186/s12906-018-2384-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Austin P.C. The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med. 2014;33:1242–1258. doi: 10.1002/sim.5984. 2013/10/15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Niu H., Alvarez-Alvarez I., Guillen-Grima F., et al. Prevalence and incidence of Alzheimer's disease in Europe: a meta-analysis. Neurologia (Engl Ed) 2017;32:523–532. doi: 10.1016/j.nrl.2016.02.016. [DOI] [PubMed] [Google Scholar]
  • 25.Carone M., Asgharian M., Jewell N.P. Estimating the lifetime risk of dementia in the Canadian elderly population using cross-sectional cohort survival data. J Am Stat Assoc. 2014;109:24–35. doi: 10.1080/01621459.2013.859076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Livingston G., Sommerlad A., Orgeta V., et al. Dementia prevention, intervention, and care. Lancet. 2017;390:2673–2734. doi: 10.1016/S0140-6736(17)31363-6. [DOI] [PubMed] [Google Scholar]
  • 27.Cheng K.J. Neurobiological mechanisms of acupuncture for some common illnesses: a clinician's perspective. J Acupunct Meridian Stud. 2014;7:105–114. doi: 10.1016/j.jams.2013.07.008. [DOI] [PubMed] [Google Scholar]
  • 28.Wong V., Cheuk D.K., Lee S., et al. Acupuncture for acute management and rehabilitation of traumatic brain injury. Cochrane Database Syst Rev. 2013 doi: 10.1002/14651858.CD007700.pub3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Zhang J.H., Wang D., Liu M. Overview of systematic reviews and meta-analyses of acupuncture for stroke. Neuroepidemiology. 2014;42:50–58. doi: 10.1159/000355435. [DOI] [PubMed] [Google Scholar]
  • 30.Cheuk D.K., Wong V. Acupuncture for epilepsy. Cochrane Database Syst Rev. 2014 doi: 10.1002/14651858.CD005062.pub4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Chan Y.Y., Lo W.Y., Yang S.N., et al. The benefit of combined acupuncture and antidepressant medication for depression: a systematic review and meta-analysis. J Affect Disord. 2015;176:106–117. doi: 10.1016/j.jad.2015.01.048. [DOI] [PubMed] [Google Scholar]
  • 32.Zhao K. Acupuncture for the treatment of insomnia. Int Rev Neurobiol. 2013;111:217–234. doi: 10.1016/B978-0-12-411545-3.00011-0. [DOI] [PubMed] [Google Scholar]
  • 33.Errington-Evans N. Acupuncture for anxiety. CNS Neurosci Ther. 2012;18:277–284. doi: 10.1111/j.1755-5949.2011.00254.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lim H.D., Kim M.H., Lee C.Y., et al. Anti-Inflammatory Effects of Acupuncture Stimulation via the Vagus Nerve. PLoS One. 2016;11 doi: 10.1371/journal.pone.0151882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Nager A.L., Kobylecka M., Pham P.K., et al. Effects of acupuncture on pain and inflammation in pediatric emergency department patients with acute appendicitis: a pilot study. J Altern Complement Med. 2015;21:269–272. doi: 10.1089/acm.2015.0024. 10.1089/act.2015.29027.sho. [DOI] [PubMed] [Google Scholar]
  • 36.Han J.S. Acupuncture and endorphins. Neurosci Lett. 2004;361:258–261. doi: 10.1016/j.neulet.2003.12.019. [DOI] [PubMed] [Google Scholar]
  • 37.Goldman N., Chen M., Fujita T., et al. Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat Neurosci. 2010;13:883–888. doi: 10.1038/nn.2562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Chen Y.H., Lee H.J., Lee M.T., et al. Median nerve stimulation induces analgesia via orexin-initiated endocannabinoid disinhibition in the periaqueductal gray. Proc Natl Acad Sci USA. 2018;115:E10720–E10729. doi: 10.1073/pnas.1807991115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Torres-Rosas R., Yehia G., Pena G., et al. Dopamine mediates vagal modulation of the immune system by electroacupuncture. Nat Med. 2014;20:291–295. doi: 10.1038/nm.3479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.BoNH and I. The National Health Insurance Annual Statistical Report. In: Yuan E, (ed.). B.o.N.H. ed. Taipei, Taiwan2010.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

mmc1.pdf (202.1KB, pdf)

Data Availability Statement

The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.


Articles from Integrative Medicine Research are provided here courtesy of Korea Institute of Oriental Medicine

RESOURCES